 |
Centruroides immune F(ab)2 |
|---|---|
| Trade Name | Anascorp |
| Orphan Indication | Scorpion envenomations requiring medical attention |
| USA Market Approval | USA |
| USA Designation Date | 2000-06-12 00:00:00 |
| Sponsor | Rare Disease Therapeutics, Inc.;12975 Brookprinter Drive, Suite 170;Poway, California, 92064 |
